The markets opened mixed with the Dow slipping 10 points to 15,071 while Nasdaq rose 10 points to 3419.
On the upside
Molycorp (NYSE: MCP) widened first quarter losses but the results were better than expected.
Sequenom (Nasdaq: SQNM) widened losses for the first quarter but revenue more than doubled.
TheStreet upgraded Tesla Motors (Nasdaq: TSLA) to a Buy rating from Hold.
On the downside
Affymax (Nasdaq: AFFY) warned in its 10-Q filing that it may never achieve profitability and may not be able to continue operations if safety concerns over OMONTYS are not rectified by Takeda Pharmaceutical.
Pfizer (NYSE: PFE) has yet to decide whether it would continuing pursuing regulatory approval of Pain Therapeutics' (Nasdaq: PTIE) abuse resistant pain treatment Remoxy. Remoxy was developed using Durect (Nasdaq: DRRX) technology.
Optimer Pharmaceuticals (Nasdaq: OPTR) widened first quarter losses more than expected.
In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 index added 2 points to 1628.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here